Feature | ASTRO | September 23, 2019

Top Radiation Oncology Research and Clinical Trials at ASTRO 2019

ASTRO highlights top-rated abstract presentations at its annual meeting

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart. #ASTRO19 #ASTRO2019 #ASTRO

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart.

August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced the top-rated studies being highlighted at the 2019 ASTRO Annual Meeting, Sept. 15 - 18 in Chicago. These presentations are being highlighted with press conferences.

Presentations Sunday, Sept. 15:

   • Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial, presented by Daniel Spratt, University of Michigan Rogel Cancer Center (Abstract LBA-1)

   • Primary Outcomes of a Phase II Randomized Trial of Observation versus Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (ORIOLE), presented by  Ryan Phillips, Johns Hopkins Kimmel Cancer Center (Abstract LBA-3)

   • Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial, presented by Julia White, The Ohio State University Comprehensive Cancer Center (Abstract 5)

   • Longer Term Results from a Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (ENCORE-VT)," presented by  Clifford Robinson, Washington University School of Medicine in St. Louis (Abstract LBA-4)

Presentations Monday, Sept. 16:

   • Final Results of a Phase II Prospective Trial Evaluating the Combination of Stereotactic Body Radiotherapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), presented by Allison Campbell, Yale Cancer Center (Abstract 74)

   • Patterns of Disease Progression with Durvalumab in Stage III NSCLC (PACIFIC), presented by Andreas Rimner, Memorial Sloan Kettering Cancer Center (Abstract LBA-6)

   • Applying a Machine Learning Approach to Predict Acute Radiation Toxicities for Head and Neck Cancer Patients, presented by Jay P. Reddy, The University of Texas MD Anderson Cancer Center (Abstract 141)

   • The Impact of the Closure of Women’s Health Clinics on Cervical Cancer in the United States, presented by Amar Srivastava, Washington University School of Medicine in St. Louis (Abstract 202)

The 2019 ASTRO Annual Meeting is expected to attract more than 10,000 oncologists, clinicians, researchers and other healthcare professionals from across the globe. Throughout the four-day meeting, researchers will present peer-reviewed abstracts on advances in clinical care for cancer patients, while panels and interactive case discussions featuring leading experts will underscore the meeting’s theme, “Innovate, Collaborate: Transform.”

 

ASTRO 2019 Video Interviews:

VIDEO: Artificial Intelligence Driven Adaptive Radiotherapy System Begins Treating Patients — Interview with David Sjostrom, Ph.D.

VIDEO: Clinical and Physics Aspects of Re-irradiation of Previously Treated Radiotherapy Tumor Sites — Interview with Kristin Higgins, M.D.

VIDEO: Cardiac Radiotherapy Ablation to Treat Ventricular Tachycardia — Interview with Clifford Robinson, M.D.

VIDEO: Understanding the Radiation Oncology Alternative Payment Model — Interview with Anne Hubbard, MBA, ASTRO

VIDEO: Preserving Neurocognitive Function During Whole-Brain Radiotherapy — Interview with Vinai Gondi, M.D.

VIDEO: Palliative Radiation Oncology For Patients Who Need Symptom Relief — Interview with Candice Johnstone, M.D.

VIDEO: Use of Hydrogel to Reduce Rectal Toxicity for Prostate Radiotherapy — Interview with Bill Hartsell, M.D.

VIDEO: Integration of Advanced Practice Providers in Radiation Oncology — Interview with Lorraine Drapek, DNP

 

Late-breaking Radiation Therapy Clinical Trials at ASTRO 2018

Find more news and video from ASTRO

 

Related Content

64-Year-Old Man With Clear Cell Likelihood Score (ccLS) 5 Renal Masses

64-Year-Old Man With Clear Cell Likelihood Score (ccLS) 5 Renal Masses. Coronal T2-weighted single shot fast spin echo and coronal T1-weighted fat-saturated spoiled gradient echo acquired during corticomedullary phase—ccLS5 lesion outlined red for clarity.

News | Magnetic Resonance Imaging (MRI) | July 22, 2021
The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

News | Radiation Oncology | July 21, 2021
July 23, 2021 — Mevion Medical Systems announced that it has delivered the 15-ton compact accelerator to...
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
ASTRO just issued the following statement in response to the Radiation Oncology Model update in yesterday's HOPPS proposed rule, which compounds significant and detrimental cuts to the cancer care specialty in the proposed 2022 MPFS

Getty Images

News | Radiation Therapy | July 20, 2021
July 20, 2021 — In response to consecutive weeks of proposed...
Artificial intelligence-powered diagnostic tool spots asymptomatic prostate cancer in seconds

(L-R) Associate Professor Peter Brotchie (St Vincent's), Dr Ruwan Tennakoon (RMIT), Professor John Thangarajah (RMIT), Dr Mark Page (St Vincent's). Image courtesy of St Vincent's Hospital Melbourne

News | Prostate Cancer | July 19, 2021
July 19, 2021 — Prostate cancer is the most diagnosed
Ramon Alfredo Siochi, Ph.D. — the director of medical physics at WVU — led a task group to help ensure the accuracy of data that dictates a cancer patient's radiation therapy.

Ramon Alfredo Siochi, director of medical physics at West Virginia University. Image courtesy of WVU Photo/Aira Burkhart

News | Radiation Oncology | July 15, 2021
July 15, 2021 — Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks s